Self-sampling device to be sent automatically, making it easier to take part in cervical cancer screening From the first week of July, every woman turning 30 will receive a self-sampling device with their invitation for cervical cancer screening. Participants can use this device to collect their own vaginal material.
No major change in air quality in the Netherlands in 2022 The overall air quality in 2022 was slightly worse than in 2021. Weather conditions such as temperature and drought played an important role in this difference. This is according to the large-scale concentration maps published by RIVM each year.
Summary International Expert Meeting on breast implant-associated lymphoma On November 19th 2018, RIVM organised an international expert meeting on a rare type of lymphoma that is associated with breast implants.
No decline in CO2 emissions since 1990 Dutch greenhouse gas emissions were 13 per cent lower in 2017 than in 1990. Emissions have been almost constant over the past five years.
RIVM will make measurements around the Sint Maarten landfill From 21 January 2019, a team from RIVM will travel to Sint Maarten to make measurements and take samples at various locations around the landfill in Philipsburg.
Explanation for difference in development ammonia emissions and concentrations Since 2005, higher ammonia concentrations have been measured in the air, despite registered emissions decreasing. New RIVM research shows that three-quarters of this difference can be explained by changes in atmospheric and chemical processes.
Application of personalised medicine: opportunities and challenges Pharmacotherapy based on individual patient characteristics such as genetic makeup, offers many potential benefits towards more effective treatment of a patients’ disease.
Strict diet combats aging diseases Mice with a severe aging disease live three times longer if they eat thirty percent less. Moreover, they age much healthier than mice that eat as much as they want.
Improved protection against pertussis The international PERISCOPE project has been granted a 30 million Euro European subsidy in order to better map the immune response to pertussis infection and vaccination.